Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Peab in connection with the listing of Annehem Fastigheter
Mandate

Vinge has advised Peab in connection with the listing of Annehem Fastigheter

December 11, 2020 Banking and Finance Capital Markets and Public M&A Corporate Tax Real Estate and Construction

Vinge has advised Peab and Annehem Fastigheter in connection with the distribution of the shares in Annehem Fastigheter to the shareholders in Peab as well as the listing of Annehem Fastigheter’s B shares on Nasdaq Stockholm. The prospectus was published 2 December 2020 and the first day of trading on Nasdaq Stockholm was 11 December 2020.

Annehem Fastigheter is a growth-driven property company specialising in commercial, community service and residential properties in the Nordic growth regions of Stockholm, Skåne, Gothenburg as well as Helsinki and Oslo. Annehem Fastigheter’s property portfolio consists of 22 investment properties with a value of SEK 3,281 million and a lettable area of 184 thousand sqm.

Vinge’s team consisted of Charlotte Levin, Rikard Lindahl, Joel Magnusson, Linnea Petersson, Assur Badur, Kristoffer Larson, Vilhelm Rondahl, Louise Brorsson Salomon, Linn Adelwald, Henrik Wastenson and Victor Ericsson.

 

Related

Vinge has advised Hansa Biopharma in connection with entering into a financing agreement

 Vinge has advised Hansa Biopharma AB (publ), a commercial-stage biopharmaceutical company on a mission to develop and commercialize innovative, lifesaving and life-altering treatments for patients with rare immunological conditions, listed on Nasdaq Stockholm, in connection with a U.S. convertible note purchase agreement comprising USD 30 million aggregate principal amount of unsecured convertible senior notes.
March 23, 2026

Vinge advises in connection with data center provider EcoDataCenter’s tap issue of SEK 500 million bonds

 Vinge has advised in connection with EcoDC Holding AB (publ)'s tap issue of SEK 500 million senior unsecured bonds under the existing framework of up to SEK 2 billion.
March 19, 2026

Vinge has advised Cinclus Pharma in connection with entering into financing agreement

 Vinge has advised Cinclus Pharma Holding AB (publ), a late-stage clinical pharmaceutical company developing next-generation treatments for gastric acid-related diseases listed on Nasdaq Stockholm, in connection with a long-term structured credit agreement for a total of up to EUR 28 million divided into four tranches, of which two are convertibles.
March 16, 2026